Thermo Fisher Scientific M&A Summary
Thermo Fisher Scientific has acquired 78 companies, including 19 in the last 5 years. A total of 31 acquisitions came from private equity firms. It has also divested 8 assets.
Thermo Fisher Scientific’s largest acquisition to date was in 2021, when it acquired Pharmaceutical Product Development for $17.4B. It’s largest disclosed sale occurred in 2019, when it sold Thermo Fisher Scientific - Anatomical Pathology Business to PHC Holdings for $1.1B. Thermo Fisher Scientific has acquired in 17 different US states, and 16 countries. The Company’s most targeted sectors include life science (36%) and test/measurement equipment (19%).
M&A Summary
-
M&A Total Activity73
- M&A Buy Activity65
- M&A Sell Activity8
- Total Sectors Invested 13
- Total Countries Invested 16
- M&A Buy/Sell Connections 42
Unlimited Searches
